GiSAS Trial: Aripiprazole, Olanzapine, and Haloperidol in the Long Term Treatment of Schizophrenia.

Trial Profile

GiSAS Trial: Aripiprazole, Olanzapine, and Haloperidol in the Long Term Treatment of Schizophrenia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Jun 2014

At a glance

  • Drugs Aripiprazole (Primary) ; Haloperidol (Primary) ; Olanzapine (Primary)
  • Indications Schizophrenia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms GiSAS
  • Most Recent Events

    • 09 Apr 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 30 Apr 2011 At the end of February 2011, 260 patients had been randomised, as reported in Contemporary Clinical Trials.
    • 27 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top